0000000000371144

AUTHOR

Andras Bilkei-gorzo

showing 5 related works from this author

Anxiety, Stress, and Fear Response in Mice With Reduced Endocannabinoid Levels

2016

Abstract Background Disruption of the endocannabinoid system through pharmacological or genetic invalidation of cannabinoid CB 1 receptors has been linked to depression in humans and depression-like behaviors in mice. The two main endogenous cannabinoids, anandamide and 2-arachidonoyl glycerol (2-AG), are produced on demand from phospholipids. The pathways and enzymes involved in endocannabinoid biosynthesis thus play a major role in regulating the activity of this system. This study investigates the role of the main 2-AG producing enzyme diacylglycerol lipase α (DAGL-α). Methods We generated and used knockout mice lacking DAGL-α ( Dagla −/− ) to assess the behavioral consequences of reduce…

0301 basic medicinemedicine.medical_specialtyDiacylglycerol lipasebiologymedicine.medical_treatmentNeurogenesisPoison controlAnandamideDepolarization-induced suppression of inhibitionEndocannabinoid systemOpen fieldDevelopmental psychology03 medical and health scienceschemistry.chemical_compound030104 developmental biology0302 clinical medicineEndocrinologychemistryInternal medicinemedicinebiology.proteinCannabinoidPsychology030217 neurology & neurosurgeryBiological PsychiatryBiological Psychiatry
researchProduct

Developmental programming of somatic growth, behavior and endocannabinoid metabolism by variation of early postnatal nutrition in a cross-fostering m…

2017

Background Nutrient deprivation during early development has been associated with the predisposition to metabolic disorders in adulthood. Considering its interaction with metabolism, appetite and behavior, the endocannabinoid (eCB) system represents a promising target of developmental programming. Methods By cross-fostering and variation of litter size, early postnatal nutrition of CB6F1-hybrid mice was controlled during the lactation period (3, 6, or 10 pups/mother). After weaning and redistribution at P21, all pups received standard chow ad libitum. Gene expression analyses (liver, visceral fat, hypothalamus) were performed at P50, eCB concentrations were determined in liver and visceral …

0301 basic medicinePhysiologyGene Expressionlcsh:MedicineAdipose tissueBiochemistryFatsMiceOvernutritionArcuate NucleusPregnancyLactationMedicine and Health SciencesCross-fosteringInsulin-Like Growth Factor Ilcsh:Sciencemedia_commonMultidisciplinaryAnimal BehaviorBrainNeurochemistryLipidsmedicine.anatomical_structureAdipose TissuePhysiological ParametersLiverAnimal SocialityFemaleAnatomyNeurochemicalsResearch Articlemedicine.medical_specialtymedia_common.quotation_subjectHypothalamusNutritional StatusIntra-Abdominal FatBiology03 medical and health sciencesInternal medicineGeneticsmedicineAnimalsHumansWeaningObesityNutritionBehaviorBody Weightlcsh:RBiology and Life SciencesAppetitemedicine.diseaseObesityDisease Models AnimalBiological Tissue030104 developmental biologyEndocrinologyDevelopmental plasticitylcsh:QZoologyBody mass indexEndocannabinoidsNeurosciencePLOS ONE
researchProduct

Age-related changes in the endocannabinoid system in the mouse hippocampus.

2015

Previous studies have demonstrated that the endocannabinoid system significantly influences the progression of brain ageing, and the hippocampus is one of the brain regions most vulnerable to ageing and neurodegeneration. We have further examined age-related changes in the hippocampal endocannabinoid system by measuring the levels of anandamide (AEA) and 2-arachidonoylglycerol (2-AG) in young and old mice from two different mouse strains. We found a decrease in 2-AG but not AEA levels in aged mice. In order to identify the cause for 2-AG level changes, we investigated the levels of several enzymes that contribute to synthesis and degradation of 2-AG in the hippocampus. We found a selective …

medicine.medical_specialtyAgingPolyunsaturated Alkamides2-ArachidonoylglycerolHippocampusmetabolism [Hippocampus]Arachidonic AcidsHippocampal formationBiologyHippocampusGlycerideschemistry.chemical_compoundMicepathology [Aging]Internal medicinemetabolism [Arachidonic Acids]medicineanandamideAnimalsglyceryl 2-arachidonateddc:610metabolism [Aging]NeurodegenerationAnandamidemedicine.diseasemetabolism [Endocannabinoids]Endocannabinoid systemMonoacylglycerol lipaseLipoprotein Lipasepathology [Hippocampus]metabolism [Polyunsaturated Alkamides]EndocrinologychemistryAgeingphysiopathology [Hippocampus]lipids (amino acids peptides and proteins)metabolism [Lipoprotein Lipase]metabolism [Glycerides]Developmental BiologyEndocannabinoidsMechanisms of ageing and development
researchProduct

Diacylglycerol lipase alpha in astrocytes is involved in maternal care and affective behaviors.

2021

Genetic deletion of cannabinoid CB1 receptors or diacylglycerol lipase alpha (DAGLa), the main enzyme involved in the synthesis of the endocannabinoid (eCB) 2-arachidonoylglycerol (2-AG), produced profound phenotypes in animal models of depression-related behaviors. Furthermore, clinical studies have shown that antagonists of CB1 can increase the incidence and severity of major depressive episodes. However, the underlying pathomechanisms are largely unknown. In this study, we have focused on the possible involvement of astrocytes. Using the highly sensitive RNAscope technology, we show for the first time that a subpopulation of astrocytes in the adult mouse brain expresses Dagla, albeit at …

0301 basic medicinemedicine.medical_specialtyCannabinoid receptormedicine.medical_treatment2-Arachidonoylglycerol610 Medicine & healthBiology03 medical and health sciencesCellular and Molecular Neurosciencechemistry.chemical_compoundMice0302 clinical medicineReceptor Cannabinoid CB1Internal medicineTripartite synapseLipidomicsmedicineAnimalsReceptorMice KnockoutDepressive Disorder MajorEndocannabinoid system3. Good healthLipoprotein Lipase030104 developmental biologyEndocrinologyNeurologychemistryAstrocytes570 Life sciences; biologylipids (amino acids peptides and proteins)Arachidonic acidFemaleCannabinoid030217 neurology & neurosurgeryEndocannabinoidsGliaREFERENCES
researchProduct

Follow up: palmitic acid ester of tetrahydrocannabinol (THC) and palmitic acid diester of 11-hydroxy-THC – unsuccessful search for additional THC met…

2020

Abstract Objectives In a previous investigation we searched for the occurrence of palmitic acid ester compounds of delta9-tetrahydrocannabinol (THC) and its primary metabolite 11-hydroxy-delta9-THC (11-OH-THC) in human body fluids and tissues (THC palmitic acid monoester [THC-Pal] and 11-OH-THC palmitic acid diester [11-OH-THC-DiPal]). As those esters could not be detected in various human body fluids (e.g. blood) or tissues (e.g. adipose tissue) we extended the investigation analyzing adipose tissue samples of mice previously given synthetic THC or a cannabis extract. Methods In total, 48 adipose tissue samples previously tested positive for THC by means of a liquid chromatographic triple …

ChromatographyChemistry11-Hydroxy-THCPalmitic AcidPrimary metaboliteAdipose tissueEstersMass spectrometricGas Chromatography-Mass SpectrometryTriple quadrupole mass spectrometerPalmitic acidMicechemistry.chemical_compoundmedicineAnimalsHumansPharmacology (medical)DronabinolGeneral Pharmacology Toxicology and PharmaceuticsTetrahydrocannabinolChromatography Liquidmedicine.drugDrug Metabolism and Personalized Therapy
researchProduct